Literature DB >> 2497132

Pregnancy outcome following early exposure to maternal luteinizing-hormone-releasing hormone agonist (buserelin).

D Dicker1, J A Goldman, I Vagman, N Eckstein, D Ayalon.   

Abstract

A human pregnancy exposed to a luteinizing-hormone-releasing hormone agonist (buserelin) in its early stages is reported. The possible mechanisms leading to conception under this mode of treatment and its consequences are discussed.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2497132     DOI： 10.1093/oxfordjournals.humrep.a136881

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


  2 in total

1.  Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study.

Authors:  A B van de-Helder; F M Helmerhorst; A Blankhart; R Brand; C Waegemaekers; N Naaktgeboren
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-12

2.  Outcome of pregnancies inadvertently exposed to gonadotropin-releasing hormone analogues (GnRH-a) in early gestation.

Authors:  Y Gonen; M Dirnfeld; H Abramovici
Journal:  J Assist Reprod Genet       Date:  1993-08       Impact factor: 3.412
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.